Daniel C Freed

Daniel C Freed

UNVERIFIED PROFILE

Are you Daniel C Freed?   Register this Author

Register author
Daniel C Freed

Daniel C Freed

Publications by authors named "Daniel C Freed"

Are you Daniel C Freed?   Register this Author

35Publications

1083Reads

17Profile Views

Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas.

Vaccines (Basel) 2019 Sep 29;7(4). Epub 2019 Sep 29.

Department of Cell and Tissue Biology, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/vaccines7040135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963214PMC
September 2019

Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection.

PLoS Pathog 2019 07 29;15(7):e1007914. Epub 2019 Jul 29.

Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.ppat.1007914DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687193PMC
July 2019

Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody.

Antimicrob Agents Chemother 2018 01 21;62(1). Epub 2017 Dec 21.

Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.01719-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740302PMC
January 2018

Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus.

Hum Vaccin Immunother 2016 08 17;12(8):2106-2112. Epub 2016 Mar 17.

a Merck Research Laboratories, Merck and Companies, Incorporated , Kenilworth , NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21645515.2016.1164376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994730PMC
August 2016

Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities.

Cell Immunol 2012 Jul-Aug;278(1-2):113-9. Epub 2012 Aug 4.

Merck Sharp & Dohme Corp., Whitehouse Station, NJ, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2012.07.006DOI Listing
January 2013

Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection.

Vaccine 2011 Nov 22;29(48):9075-80. Epub 2011 Sep 22.

Department of Vaccine Research, Merck Research Laboratories, WP16-200, 770 Sumneytown Pike, West Point, PA 19486, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2011.09.056DOI Listing
November 2011

Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulations.

Vaccine 2011 Nov 11;29(50):9385-90. Epub 2011 Oct 11.

Department of Vaccine Basic Research, Department of Vaccine Processing Research and Development, Merck Research Laboratories, West Point, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2011.09.122DOI Listing
November 2011

A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines.

Vaccine 2011 Oct 31;29(46):8350-6. Epub 2011 Aug 31.

Vaccines Research, Merck Research Laboratories, West Point, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2011.08.086DOI Listing
October 2011

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys.

Vaccine 2009 Feb 13;27(9):1440-7. Epub 2009 Jan 13.

Department of Vaccine Basic Research, Merck Research Laboratories, West Point, PA 19486, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2008.12.034DOI Listing
February 2009